The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMBRX BIOPHARMA INC | SPONSORED ADS | 02290A102 | 3,232,524 | 281,089 | SH | SOLE | 281,089 | 0 | 0 | |||
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 4,992,954 | 272,690 | SH | SOLE | 272,690 | 0 | 0 | |||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 6,915,862 | 181,805 | SH | SOLE | 181,805 | 0 | 0 | |||
| ARDELYX INC | COM | 039697107 | 3,595,932 | 881,356 | SH | SOLE | 881,356 | 0 | 0 | |||
| AXSOME THERAPEUTICS INC | COM | 05464T104 | 7,729,834 | 110,600 | SH | SOLE | 110,600 | 0 | 0 | |||
| BLACK DIAMOND THERAPEUTICS I | COM | 09203E105 | 1,820,128 | 634,191 | SH | SOLE | 634,191 | 0 | 0 | |||
| COMPASS THERAPEUTICS INC | COM | 20454B104 | 1,801,821 | 914,630 | SH | SOLE | 914,630 | 0 | 0 | |||
| CONTEXT THERAPEUTICS INC | COM | 21077P108 | 1,096,186 | 725,951 | SH | SOLE | 725,951 | 0 | 0 | |||
| CYTOKINETICS INC | COM NEW | 23282W605 | 6,580,834 | 223,382 | SH | SOLE | 223,382 | 0 | 0 | |||
| GERON CORP | COM | 374163103 | 4,709,875 | 2,221,639 | SH | SOLE | 2,221,639 | 0 | 0 | |||
| INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 9,115,750 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | |||
| JASPER THERAPEUTICS INC | COM | 471871103 | 2,200,915 | 3,144,164 | SH | SOLE | 3,144,164 | 0 | 0 | |||
| MEDAVAIL HOLDINGS INC | COM NEW | 58406B202 | 707,382 | 117,897 | SH | SOLE | 117,897 | 0 | 0 | |||
| MERUS NV | COM | N5749R100 | 5,220,235 | 221,384 | SH | SOLE | 221,384 | 0 | 0 | |||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 3,061,527 | 70,283 | SH | SOLE | 70,283 | 0 | 0 | |||
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 10,436,985 | 183,105 | SH | SOLE | 183,105 | 0 | 0 | |||
| PRAXIS PRECISION MEDICINES I | COM | 74006W108 | 1,806,393 | 1,056,370 | SH | SOLE | 1,056,370 | 0 | 0 | |||
| PROMIS NEUROSCIENCES INC | COM NEW | 74346M406 | 1,053,351 | 531,915 | SH | SOLE | 531,915 | 0 | 0 | |||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 9,119,388 | 266,961 | SH | SOLE | 266,961 | 0 | 0 | |||